07 Fakultät Konstruktions-, Produktions- und Fahrzeugtechnik

Permanent URI for this collectionhttps://elib.uni-stuttgart.de/handle/11682/8

Browse

Search Results

Now showing 1 - 4 of 4
  • Thumbnail Image
    ItemOpen Access
    FeaSel-Net : a recursive feature selection callback in neural networks
    (2022) Fischer, Felix; Birk, Alexander; Somers, Peter; Frenner, Karsten; Tarín, Cristina; Herkommer, Alois
    Selecting only the relevant subsets from all gathered data has never been as challenging as it is in these times of big data and sensor fusion. Multiple complementary methods have emerged for the observation of similar phenomena; oftentimes, many of these techniques are superimposed in order to make the best possible decisions. A pathologist, for example, uses microscopic and spectroscopic techniques to discriminate between healthy and cancerous tissue. Especially in the field of spectroscopy in medicine, an immense number of frequencies are recorded and appropriately sized datasets are rarely acquired due to the time-intensive measurements and the lack of patients. In order to cope with the curse of dimensionality in machine learning, it is necessary to reduce the overhead from irrelevant or redundant features. In this article, we propose a feature selection callback algorithm (FeaSel-Net) that can be embedded in deep neural networks. It recursively prunes the input nodes after the optimizer in the neural network achieves satisfying results. We demonstrate the performance of the feature selection algorithm on different publicly available datasets and compare it to existing feature selection methods. Our algorithm combines the advantages of neural networks’ nonlinear learning ability and the embedding of the feature selection algorithm into the actual classifier optimization.
  • Thumbnail Image
    ItemOpen Access
    Data-driven development of sparse multi-spectral sensors for urological tissue differentiation
    (2023) Fischer, Felix; Frenner, Karsten; Granai, Massimo; Fend, Falko; Herkommer, Alois
  • Thumbnail Image
    ItemOpen Access
    Two-wavelength digital holography through fog
    (2023) Gröger, Alexander; Pedrini, Giancarlo; Fischer, Felix; Claus, Daniel; Aleksenko, Igor; Reichelt, Stephan
  • Thumbnail Image
    ItemOpen Access
    Data-driven identification of biomarkers for in situ monitoring of drug treatment in bladder cancer organoids
    (2022) Becker, Lucas; Fischer, Felix; Fleck, Julia L.; Harland, Niklas; Herkommer, Alois; Stenzl, Arnulf; Aicher, Wilhelm K.; Schenke-Layland, Katja; Marzi, Julia
    Three-dimensional (3D) organoid culture recapitulating patient-specific histopathological and molecular diversity offers great promise for precision medicine in cancer. In this study, we established label-free imaging procedures, including Raman microspectroscopy (RMS) and fluorescence lifetime imaging microscopy (FLIM), for in situ cellular analysis and metabolic monitoring of drug treatment efficacy. Primary tumor and urine specimens were utilized to generate bladder cancer organoids, which were further treated with various concentrations of pharmaceutical agents relevant for the treatment of bladder cancer (i.e., cisplatin, venetoclax). Direct cellular response upon drug treatment was monitored by RMS. Raman spectra of treated and untreated bladder cancer organoids were compared using multivariate data analysis to monitor the impact of drugs on subcellular structures such as nuclei and mitochondria based on shifts and intensity changes of specific molecular vibrations. The effects of different drugs on cell metabolism were assessed by the local autofluorophore environment of NADH and FAD, determined by multiexponential fitting of lifetime decays. Data-driven neural network and data validation analyses (k-means clustering) were performed to retrieve additional and non-biased biomarkers for the classification of drug-specific responsiveness. Together, FLIM and RMS allowed for non-invasive and molecular-sensitive monitoring of tumor-drug interactions, providing the potential to determine and optimize patient-specific treatment efficacy.